Gaspar A. Pacheco

Safety and Immunogenicity of an Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in a Subgroup of Healthy Adults in Chile

Susan M. Bueno, Katia Abarca, Pablo A. González et al. · Clinical Infectious Diseases · 2021 · 109 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated Vaccine

Felipe Melo-González, Jorge A. Soto, Liliana A González et al. · Frontiers in Immunology · 2021 · 83 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +12

Immune Profile and Clinical Outcome of Breakthrough Cases After Vaccination With an Inactivated SARS-CoV-2 Vaccine

Luisa F. Duarte, Nicolás M. S. Gálvez, Carolina Iturriaga et al. · Frontiers in Immunology · 2021 · 67 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Interim report: Safety and immunogenicity of an inactivated vaccine against SARS-CoV-2 in healthy chilean adults in a phase 3 clinical trial

Susan M. Bueno, Katia Abarca, Pablo A. González et al. · medRxiv · 2021 · 59 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

A Booster Dose of CoronaVac Increases Neutralizing Antibodies and T Cells that Recognize Delta and Omicron Variants of Concern

Bárbara M. Schultz, Felipe Melo-González, Luisa F. Duarte et al. · mBio · 2022 · 45 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17